Balaji Amines Ltd
NSE:BALAMINES

Watchlist Manager
Balaji Amines Ltd Logo
Balaji Amines Ltd
NSE:BALAMINES
Watchlist
Price: 1 949.6 INR -0.24% Market Closed
Market Cap: 63.2B INR
Have any thoughts about
Balaji Amines Ltd?
Write Note

Net Margin
Balaji Amines Ltd

13.2%
Current
14%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.2%
=
Net Income
2B
/
Revenue
15.3B

Net Margin Across Competitors

Country IN
Market Cap 63.2B INR
Net Margin
13%
Country US
Market Cap 86.9B USD
Net Margin
11%
Country US
Market Cap 68B USD
Net Margin
13%
Country JP
Market Cap 10.2T JPY
Net Margin
21%
Country CH
Market Cap 36.4B CHF
Net Margin
15%
Country CN
Market Cap 234.5B CNY
Net Margin
8%
Country US
Market Cap 32.1B USD
Net Margin
7%
Country US
Market Cap 27.9B USD
Net Margin
8%
Country CH
Market Cap 25.9B EUR
Net Margin
20%
Country IN
Market Cap 2.2T INR
Net Margin
13%
Country DK
Market Cap 165.6B DKK
Net Margin
17%
No Stocks Found

Balaji Amines Ltd
Glance View

Market Cap
63.2B INR
Industry
Chemicals

Balaji Amines Ltd. manufactures, sells and exports methylamines, ethylamines and derivatives of specialty chemicals and pharma excipients in India. The company is headquartered in Secunderabad, Telangana and currently employs 1,071 full-time employees. The firm is running a five-star hotel in Solapur, Maharashtra, namely Balaji Sarovar Premiere. The firm operates through three segments: Specialty Chemicals and Amines, Hotel and CFL Lamps. Its amines products include MONOMETHYLAMINE (MMA), DIMETHYLAMINE (DMA) and TRIMETHYLAMINE (TMA). Its specialty chemicals include N-Methyl Pyrrolidone (NMP), Morpholine, 2-PYRROLIDONE (2-P), N-ETHYL-2-PYRROLIDONE, GAMMA-BUTYROLACTONE, ACETONITRILE (ACN) and DIMETHYLFORMAMIDE (DMF). Its derivatives include Di-Methyl Acetamide (DMAC), Di-Ethyl Amine Hydrochloride (DMA HCL), Tri-Ethyl Amine Hydrochloride (TEA HCL), Di-Ethyl Amine Hydrochloride (DEA HCL) and Tri-Methyl Amine Hydrochloride (TMA HCL). Its pharma excipients include POLY VINYL PYRROLIDONE(PVP-30) IP/BP/JP GRADE and POLY VINYL PYRROLIDONE(PVP-30)-TECHNICAL GRADE.

BALAMINES Intrinsic Value
2 505.4 INR
Undervaluation 22%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
13.2%
=
Net Income
2B
/
Revenue
15.3B
What is the Net Margin of Balaji Amines Ltd?

Based on Balaji Amines Ltd's most recent financial statements, the company has Net Margin of 13.2%.